NEJM Group Partners With GetFTR on Access
The collaboration aims to make NEJM Group's medical research easier to discover and access through GetFTR's access indicators.
Updated on Nov. 19, 2026 in Healthcare

NEJM Group, publisher of the New England Journal of Medicine, has partnered with GetFTR to improve discovery and access to its medical research content. GetFTR functionality will be incorporated into article references on NEJM Group's journal platform.
Why it matters
Researchers and healthcare professionals increasingly rely on multiple platforms, AI assistants, and online resources to find scientific information, and the partnership is designed to help them identify full-text availability. The integration is expected to benefit publishers, libraries, and research institutions.
The partnership covers NEJM Group's full portfolio, which includes the New England Journal of Medicine, NEJM Evidence, NEJM AI, and NEJM Catalyst. No specific financial or usage metrics were disclosed in the announcement.
The players
NEJM Group
NEJM Group is the publisher of the New England Journal of Medicine, NEJM Evidence, NEJM AI, and NEJM Catalyst, with publications issued by the Massachusetts Medical Society.
GetFTR
GetFTR is a service that provides free browser-based access indicators and smart links to full-text scholarly articles across research platforms.
The details
Users of discovery services and research tools connected to GetFTR will be able to view access indicators for NEJM Group content, and smart links will direct them to the authoritative full text. GetFTR's free browser extension already displays access indicators and links to full-text articles on websites that cite scholarly content, and NEJM Group has been added to its network of publishers and research platforms.
Industry Context
The move extends GetFTR's access-indicator network, which already links scholarly citations to full-text articles, by adding one of medicine's most cited journal publishers. It reflects a broader push by publishers to make paywalled research discoverable inside the tools researchers already use.
Readers searching for medical studies may find full-text availability indicators appear alongside citations once the integration is live. The change affects how easily researchers, clinicians, and librarians can locate and open NEJM Group articles.
The takeaway
Tools that show whether a cited study is freely available can save time when verifying medical evidence. Checking access indicators before searching elsewhere is a practical way to reach the authoritative full text.
Further reading
For related coverage, explore Healthcare industry news.
Source note: This article includes information reported by Knowledgespeak.






